Skip to content

To Evaluate the Effectiveness and Safety of Single-port Robotic-assisted Subcutaneous Gland Resection in Males

A Prospective, Single-center, Single-arm Clinical Study to Evaluate the Effectiveness and Safety of Single-port Robotic-assisted Subcutaneous Gland Resection in Males

Status
Not yet recruiting
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT07353411
Enrollment
20
Registered
2026-01-20
Start date
2026-01-01
Completion date
2028-11-30
Last updated
2026-01-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Gynecomastia

Keywords

Single-port Robotic-assisted subcutaneous gland resection

Brief summary

The new technology of robotic surgery system, as an emerging technology, has shown certain application prospects in breast surgery. However, the new technology of robotic surgery system in China in the treatment of gynecomastia is still in the exploratory stage and needs to be further improved. This prospective, single-center, single-arm clinical study was conducted to use the single-port robot and evaluate the effectiveness and safety of the subcutaneous gland resection in the treatment of gynecomastia.

Detailed description

The new technology of robotic surgery system, as an emerging technology, has shown certain application prospects in breast surgery. However, the new technology of robotic surgery system in China in the treatment of gynecomastia is still in the exploratory stage and needs to be further improved. This prospective, single-center, single-arm clinical study was conducted to use the single-port robot and evaluate the effectiveness and safety of the subcutaneous gland resection in the treatment of gynecomastia.

Interventions

PROCEDURESingle-port Robotic-assisted Subcutaneous Gland Resection in males

Single-port Robotic-assisted Subcutaneous Gland Resection for males in the treatment of gynecomastia.

Sponsors

The First Affiliated Hospital with Nanjing Medical University
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT
Masking
NONE

Intervention model description

Single-port Robotic-assisted Subcutaneous Gland Resection for males in the treatment of gynecomastia.

Eligibility

Sex/Gender
MALE
Age
17 Years to 75 Years
Healthy volunteers
Yes

Inclusion criteria

1. Male patients, aged 18-75 years old; 2. Preoperative breast ultrasound indicates male breast development, and breast enlargement symptoms persist for more than 1 year; 3. Primary male breast development that has been unresponsive to drug treatment, or those who refuse drug treatment; 4. According to Gynecomastia's surgical indications, refer to the "2023 Expert consensus on the clinicaldiagnosis and treatment of gynecomastia in China" Simon grading of male breast development IIb or above; 5. Due to social pressure or severe psychological burden caused by symptoms such as breast pain, those who have a strong desire for surgery may experience psychological burden caused by the disease and actively request surgery; 6. Individuals without serious accompanying diseases; 7. Suspected malignant transformation; 8. No other serious underlying diseases in the past; 9. The surgical procedure includes a single hole robot (intraperitoneal endoscopic single hole surgical system SP1000) for subcutaneous gland resection of the breast; 10. Participants are able to understand the research process, voluntarily join the study, sign informed consent forms, have good compliance, and cooperate with follow-up; 11. No swallowing difficulties; No shoulder joint movement disorders; 12. Complete clinical data.

Exclusion criteria

1. Age\<16 years old, still in puberty, or disease duration ≤ 1 year; 2. Simple obesity, no obvious glandular tissue was found on breast ultrasound examination; 3. Male patients with breast developmental disorders secondary to other diseases; 4. Patients with contraindications for general anesthesia surgery such as coagulation dysfunction and severe cardiovascular disease, who cannot tolerate surgery; 5. The clinical data is basically incomplete; 6. Other surgical methods; 7. Individuals with a history of breast surgery or breast tumors in the past; 8. The serious diseases of non malignant tumors such as congenital testicular hypoplasia syndrome, cirrhosis, primary hypogonadism, and hyperthyroidism will affect the patient's compliance or put the patient in a dangerous state; 9. Dementia, intellectual disability, or any mental illness that hinders understanding of informed consent forms; 10. Lack of trust in surgical outcomes and weak desire for surgery.

Design outcomes

Primary

MeasureTime frameDescription
Patient's and doctor's satisfaction2 yearsUse the Health Status Survey Questionnaire (SF-36) to assess the general condition of patients.
Patient's psychological status using the Self Rating Anxiety Scale (SAS)2 yearsUse the Self Rating Anxiety Scale (SAS) to assess the psychological status of patients.
Patient's psychological status2 yearsUse the Self Rating Depression Scale (SDS) to assess the psychological status of patients.
Patient's sensory2 yearsUsing Semmes Weinstein (S-W) monofilament to detect postoperative sensory recovery in patients.

Contacts

CONTACTQiang Ding, Professor
dingqiang@njmu.edu.cn13951731373

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026